Intercept Pharmaceuticals, Inc.

Overview

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. It is known for its research and development in areas like Primary Biliary Cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).

Therapeutic areas

Liver DiseasesFibrosisPrimary Biliary CholangitisNonalcoholic Steatohepatitis

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Intercept Pharmaceuticals, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Intercept Pharmaceuticals, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.